BCIDP study guide
BCIDP · Work through your exam, one topic at a time.
The Board Certified Infectious Diseases Pharmacist (BCIDP) credential is a specialty certification for licensed pharmacists who have built a practice in infectious diseases pharmacy - antimicrobial stewardship, clinical ID consult services, transplant and critical care ID, or outpatient parenteral therapy. It signals to employers and credentialing committees that a pharmacist can independently reason through complex microbiology, antimicrobial pharmacology, and syndrome-specific management. The BCIDP study guide has 7 sections and about 1,702 words.
01Microbiology, Pathophysiology, and Immunology of Infectious Diseases
Candidates must connect organism biology to clinical behavior. Know the major bacterial classes (gram-positive cocci and bacilli, gram-negative rods and cocci, anaerobes, atypicals such as Mycoplasma , Chlamydia , Legionella ), their typical niches, and their intrinsic resistance patterns (e.g., Enterococcus vs.
294 words, about 1 min02Pharmacology and Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents
Understand time-dependent vs. concentration-dependent killing and the pharmacodynamic indices that predict efficacy: fT MIC (beta-lactams), Cmax/MIC (aminoglycosides), and AUC/MIC (vancomycin, fluoroquinolones, azithromycin).
243 words, about 1 min03Antimicrobial Stewardship and Infection Prevention
Stewardship aims to improve outcomes while minimizing harm: appropriate indication, agent, dose, duration, and de-escalation. Know the core interventions (prospective audit and feedback, formulary restriction/preauthorization, rapid diagnostics, IV-to-PO conversion, allergy assessment, and syndrome-specific pathways).
257 words, about 1 min04Clinical Management of Infectious Diseases Syndromes
Approach each syndrome by site, host, and likely pathogen. Know empiric regimens and when to narrow.
230 words, about 1 min05Special Populations and Antimicrobial Dosing Considerations
Dosing must adapt to altered physiology. In renal impairment, adjust renally cleared drugs (aminoglycosides, vancomycin, most beta-lactams) by extending interval, reducing dose, or both.
244 words, about 1 min06Diagnostic Testing, Susceptibility Interpretation, and Therapeutic Drug Monitoring
Know the diagnostic modalities: culture (blood, urine, sputum, sterile sites), Gram stain, rapid molecular assays (PCR, NAAT), antigen tests, serology, and biomarker tests (procalcitonin, CRP). Understand susceptibility testing: MIC, disk diffusion, broth microdilution, and automated systems.
236 words, about 1 min07Patient Safety, Adverse Effects, Drug Interactions, and Regulatory/Professional Practice
Know the major adverse effects by class: beta-lactams (hypersensitivity, C. difficile , seizures with high-dose carbapenems), aminoglycosides (nephrotoxicity, ototoxicity), vancomycin (nephrotoxicity, infusion reaction), fluoroquinolones (tendinopathy, QT prolongation, CNS effects, aortic risk), macrolides (QT prolongation, interactions via CYP3A4), azoles (hepatotoxicity, QT, CYP interactions), and linezolid (thrombocytopenia, serotonin syndrome with serotonergic drugs).
198 words, under 1 min